Showing results (1381-1390 of 1,397) with videos related to
Sort By:
Pageof 140
The Lancet. Infectious Diseases|June 30, 2026
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trialHong-Xing Pan, Zhao-Feng Bi, Yu-Lin Jing, et al.Cancer Cell|May 16, 2019
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA VariantsBryan D Smith, Michael D Kaufman, Wei-Ping Lu, et al.Current Medical Science|August 9, 2020
Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 CasesYong Gao, Hai-Bo Qiu, Shu Zhou, et al.Nature Genetics|November 4, 2024
Grapevine pangenome facilitates trait genetics and genomic breedingZhongjie Liu, Nan Wang, Ying Su, et al.Nature Communications|July 2, 2025
Single-cell signaling network profiling during redox stress reveals dynamic redox regulation in immune cellsYi-Chuan Wang, Ping-Hsun Wu, Wen-Chieh Ting, et al.Annals of Internal Medicine|November 22, 2021
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysisCho-Han Chiang, Cho-Hung Chiang, John W Pickering, et al.Science Advances|November 29, 2023
<i>ROBO1</i> deficiency impairs HSPC homeostasis and erythropoiesis via <i>CDC42</i> and predicts poor prognosis in MDSJia-Cheng Jin, Bing-Yi Chen, Chu-Han Deng, et al.The Lancet. Infectious Diseases|August 29, 2022
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trialFang-Hui Zhao, Ting Wu, Yue-Mei Hu, et al.JAMA|August 8, 2020
Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death ProjectDavid M Greer, Sam D Shemie, Ariane Lewis, et al.Cell Stem Cell|June 18, 2013
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristicsSibgat Choudhury, Vanessa Almendro, Vanessa F Merino, et al.Pageof 140